Dr. Omar Alkharabsheh, MD

Dr. Alkharabsheh practices at UC Medical Center in Cincinnati, Ohio.

Dr. Alkharabsheh's NPI, 1306124813, was assigned on August 1, 2011. Dr. Alkharabsheh graduated from Jordan University of Science and Technology FOM in 2008. Dr. Alkharabsheh's Alabama license number on file is MD.36911.

Dr. Alkharabsheh's primary practice is UC Medical Center, at 3188 Bellevue Ave, Cincinnati, OH 45219 in Hamilton County. The practice phone is (513) 584-1000.

Dr. Alkharabsheh's primary practice is UC Medical Center in Cincinnati, Ohio. Dr. Alkharabsheh is also affiliated with University of Cincinnati Medical Center. The medical group on file is University of Cincinnati Physicians. Dmand AI also links Dr. Alkharabsheh to 1 more hospital, 2 group practices and clinics and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Alkharabsheh practices, 4 sites in all. Vendor and product names are available with a free account.

Hematology and oncology is Dr. Alkharabsheh's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Alkharabsheh is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Alkharabsheh's licenses on file in 4 states: Alabama, Ohio, Minnesota and Michigan.

Dmand AI lists chronic anemia, chronic leukemia, deep vein thrombosis (DVT), lung cancer, lymphoma, multiple myeloma, neutropenia and prostate cancer among the conditions Dr. Alkharabsheh treats.

CMS data shows 427 Medicare services from Dr. Alkharabsheh across 7 procedure codes in 2024, for 152 Medicare patients. Medicare paid $28,051 for them.

CMS counts 152 Medicare patients who saw Dr. Alkharabsheh in 2024. The largest group is 65 to 74, with 64 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 2.12, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Alkharabsheh's median patient age at 64, with 49% women.

In 2024, Dr. Alkharabsheh wrote 897 Medicare Part D claims for 134 patients. 69% of them were for generic drugs. CMS names the drug for 698 of them, across 22 drugs with 11 or more claims each, at $3,884,446 in total drug cost. In 2023, CMS named 689 claims across 25 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Alkharabsheh for performance year 2024, reported as part of a group. Dr. Alkharabsheh accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 26 papers to Dr. Alkharabsheh, published from 2016 to 2025. 2018 was the busiest year, with 4. The most frequent topics are Myelodysplastic Syndromes and Multiple Myeloma. Dr. Alkharabsheh has published most often in Am J Hematol. Dr. Alkharabsheh's most frequent co-authors are Moh'D M Th Khushman, MD, Nausheen Ahmed, MD and Aref Al-Kali, MD.

Dmand AI links Dr. Alkharabsheh to 4 clinical trials, 2 of them phase 3 studies. 3 are still active or recruiting. Conditions studied include Hodgkin Disease, Leukemia, Lymphocytic, Chronic, B-Cell and Lymphoma, T-Cell, Peripheral. Open Payments lists research payments to Dr. Alkharabsheh that name 1 trial.

CMS Open Payments shows 503 general payments to Dr. Alkharabsheh from 50 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 64% of the total. Genentech, Inc. paid the most, $5,228. It also lists 1 research payment totaling $8 in 2022, naming 1 clinical trial.

Dr. Alkharabsheh graduated from Jordan University of Science and Technology FOM in 2008. Dr. Alkharabsheh is a member of ASCO and ASH.

Dr. Alkharabsheh is in network with 19 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.